Skip to content

13F-HR filed by Birchview Capital, LP

Birchview Capital, LP filed this 13F-HR for the quarter ended 2017-03-31, filed 2017-05-04, with 41 holding rows worth $179,824,000.

Accession
0001618205-17-000002
Filed
2017-05-04
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2017

A holdings report, 0 entries on the cover page, a total value of $179,824,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $179,824,000 with VALUE read as thousands by filing date, 13F file number 028-16416. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
CELGENE CORP151020104COM767,051$95,444,000thousands by filing date
Accelerate Diagnostics00430H102COM2,183,795$52,848,000thousands by filing date
VERMILLION INC92407M206COM NEW2,752,933$5,649,000thousands by filing date
EQT CORP COM26884L109Stock42,300$2,585,000thousands by filing date
BIOLASE INC090911108COMMON STOCK1,285,903$1,736,000thousands by filing date
ENCANA CORP292505104COM132,300$1,549,000thousands by filing date
MASIMO CORP COM574795100Stock15,000$1,399,000thousands by filing date
TESARO INC881569107COM9,000$1,385,000thousands by filing date
CONTRAFECT CORP212326102COM725,082$1,305,000thousands by filing date
NEUROCRINE BIOSCIENCES INC64125C109COM25,200$1,091,000thousands by filing date
OXFORD IMMUNOTEC GLOBAL PLCG6855A103ORD SHS67,303$1,043,000thousands by filing date
Merck & Co.,Inc.58933Y105COM15,000$953,000thousands by filing date
WRIGHT MED GROUP INC98235T107COM30,000$934,000thousands by filing date
QUIDEL CORP74838J101COM38,975$882,000thousands by filing date
VERACYTE INC COM92337F107Stock94,767$870,000thousands by filing date
YIELD10 BIOSCIENCE INC98585K102COM2,263,166$807,000thousands by filing date
NXSTAGE MEDICAL INC67072V103COMMON STOCK28,200$757,000thousands by filing date
VANDA PHARMACEUTICALS INC921659108COM54,000$756,000thousands by filing date
WORKHORSE GROUP INC98138J206COM NEW260,000$684,000thousands by filing date
CORCEPT THERAPEUTICS INC218352102COM60,000$658,000thousands by filing date
CLOVIS ONCOLOGY INC189464100COM10,000$637,000thousands by filing date
PIONEER NATURAL RESOURCES CO723787107COM3,000$559,000thousands by filing date
SIENTRA INC82621J105COM63,300$533,000thousands by filing date
COTERRA ENERGY INC COM127097103Stock21,000$502,000thousands by filing date
QUOTIENT LTDG73268107SHS58,200$407,000thousands by filing date
SINGLE TOUCH SYSTEMS INC82988R203COM140,000$360,000thousands by filing date
ONCOMED PHARMACEUTICALS INC COM68234X102Stock34,689$319,000thousands by filing date
CELGENE CORP151020112RIGHT 12/31/2030291,877$315,000thousands by filing date
ALDER BIOPHARMACEUTICALS INC014339105COM15,150$315,000thousands by filing date
XENCOR INC98401F105COMMON STOCK12,300$294,000thousands by filing date
ADVAXIS INC007624208COM NEW35,600$291,000thousands by filing date
ADVANCED ACCELERATOR APPLIC SPONSORED ADS00790T100ADR7,000$279,000thousands by filing date
BIOGEN INC COM09062X103Stock1,000$273,000thousands by filing date
GENOCEA BIOSCIENCES INC372427104COM39,000$238,000thousands by filing date
PARATEK PHARMACEUTICALS INC699374302Equity11,150$215,000thousands by filing date
OPKO HEALTH INC68375N103COM24,158$193,000thousands by filing date
ACCURAY INC DEL004397105COM40,300$191,000thousands by filing date
ROKA BIOSCIENCE INC775431109COM46,731$166,000thousands by filing date
PACIFIC BIOSCIENCES CALIF INC COM69404D108Stock27,000$140,000thousands by filing date
MERRIMACK PHARMACEUTICALS IN590328100COM44,000$136,000thousands by filing date
AEVI GENOMIC MEDICINE INC00835P105COM68,000$126,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001618205-17-000002this filing2017-05-04acceptance time not in the bulk data set